00000nam 2200000za 4500 9.856866 CaOODSP 20221107155631 cr ||||||||||| 180523s2018 onc o f000 0 eng d 9780660266626 CaOODSP eng n-cn--- H13-9/13-2018E-PDF Guidance document [electronic resource] : fees for the right to sell drugs. Fees for the right to sell drugs Ottawa : Health Canada, 2018. 15 p. Issued also in French under title: Ligne directrice : frais à payer le droit de vendre une drogue. Cover title. "Date adopted: 1998/05. Revised date: 2018/06/13. Effective date: 2018/06/13." "Publication date: June 2018." Issued also in HTML format. "This document provides guidance on the interpretation of the Fees in Respect of Drugs and Medical Devices Regulations (Fee Regulations) with a focus on how the Fees for the Right to Sell Drugs, contained in Part 2, Division 4 of these regulations, will be administered"--Introd., p. 7. gccst Pharmaceutical industry gccst Retail trade gccst Government policy Canada. Health Canada. Ligne directrice (CaOODSP)9.856867 Guidance document : (CaOODSP)9.866809 PDF 315 KB https://publications.gc.ca/collections/collection_2018/sc-hc/H13-9-13-2018-eng.pdf HTML N/A https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/fees/guidance-document-fees-right-sell-drugs.html 180095